Purification of HSCs from the stem cell grafts using CD34 selection may be performed to reduce the risk of reinfusing autoreactive lymphocytes into the patient, but this purging is associated with excess infection due to delayed immune reconstitution and the selection procedure adds significantly to the costs and logistics of the procedure [30]. The gene discussed is CD34; the disease is infection.